The Latest
Letters to OfficialsCCAGW Urges Senate Homeland Security and Government Affairs Committee to Support S. 2871
S. 2871 would make federal agencies more secure and efficient while reducing costs and duplication.
State ActionCCAGW Urges Pennsylvania Legislators to Oppose Senate Bill 1000
SB 1000 creates unnecessary regulatory barriers that will undermine the effectiveness of PBMs in Pennsylvania.
The WasteWatcherACP Funding Expiration Will Affect States’ Broadband Rate Regulation
Ending ACP will complicate and delay state efforts to expand affordable internet access.
State ActionCCAGW Urges Kansas Legislators to Oppose Amendment to SB 514
The move to amend Substitute for SB 514 will change how the federal 340B drug pricing program operates in the Sunflower State.
The WasteWatcherFTC Chair Khan Should Focus on Production and Prices Instead of Political Pressure
Mergers should be reviewed based on their benefits to consumers, not pressure from members of Congress.
State ActionCCAGW Urges Governor Reeves to Veto House Bill 728
HB 728 would change how the federal 340B program operates in Mississippi.
The WasteWatcherThe FCC's Not So Merry-Go-Round of Net Neutrality
The Biden administration’s creates uncertainty for future of broadband deployments across America and wastes taxpayer resources.
Op-EdsA ‘D’ for the USPS Delivering for America plan
The USPS delivers at least one thing consistently. It has lost money in every quarter since 2007.
The WasteWatcherPresident Biden's Budget Will Raise Taxes and Federal Debt
President Biden's FY 2025 budget would increase government spending, restore IRS funding, and raise taxes
The 340B Drug Pricing Program Needs a New Prescription
Federal healthcare programs are often well-intended but end up costing more than expected and become subject to waste, fraud, abuse, and mismanagement.
The WasteWatcherRate Setting for BEAD Funds Is Forcing States to Consider the Impact of Inflation
NTIA's pressure to include unrealistic price caps without inflation adjustment may discourage provider participation.
State ActionCCAGW Urges Kentucky Representatives to Oppose SB 188
SB 188 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmaceutical benefit managers (PBMs) in Kentucky.
